1. AHRO : Austin Health Research Online

John M Mariadason

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
John M Mariadason
Full Name
Mariadason, John M
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 41-57 of 57 (Search time: 0.008 seconds).

Publication YearTitleAuthor(s)
4128-Jun-2017PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation.Tutuka, Candani S A; Andrews, Miles C; Mariadason, John M ; Ioannidis, Paul; Hudson, Christopher; Cebon, Jonathan S ; Behren, Andreas
426-Mar-2017Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.Mateo-Lozano, Silvia; Bazzocco, Sarah; Rodrigues, Paulo; Mazzolini, Rocco; Andretta, Elena; Dopeso, Higinio; Fernández, Yolanda; Del Llano, Edgar; Bilic, Josipa; Suárez-López, Lucía; Macaya, Irati; Cartón-García, Fernando; Nieto, Rocio; Jimenez-Flores, Lizbeth M; de Marcondes, Priscila Guimarães; Nuñez, Yaiza; Afonso, Elsa; Cacci, Karina; Hernández-Losa, Javier; Landolfi, Stefania; Abasolo, Ibane; Ramón Y Cajal, Santiago; Mariadason, John M ; Schwartz, Simo; Matsui, Toshimitsu; Arango, Diego
43Jun-2016Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.Tögel, Lars; Nightingale, Rebecca; Chueh, Anderly C; Jayachandran, Aparna; Tran, Hoanh; Phesse, Toby; Wu, Rui; Sieber, Oliver M; Arango, Diego; Dhillon, Amardeep S; Dawson, Mark A; Diez-Dacal, Beatriz; Gahman, Timothy C; Filippakopoulos, Panagis; Shiau, Andrew K; Mariadason, John M 
44Jan-2016Colorectal cancer atlas: an integrative resource for genomic and proteomic annotations from colorectal cancer cell lines and tissuesChisanga, David; Keerthikumar, Shivakumar; Pathan, Mohashin; Ariyaratne, Dinuka; Kalra, Hina; Boukouris, Stephanie; Abraham Mathew, Nidhi; Al Saffar, Haidar; Gangoda, Lahiru; Ang, Ching-Seng; Sieber, Oliver M; Mariadason, John M ; Dasgupta, Ramanuj; Chilamkurti, Naveen; Mathivanan, Suresh
45Aug-2015FunRich: An open access standalone functional enrichment and interaction network analysis tool.Pathan, Mohashin; Keerthikumar, Shivakumar; Ang, Ching-Seng; Gangoda, Lahiru; Quek, Camelia Y J; Williamson, Nicholas A; Mouradov, Dmitri; Sieber, Oliver M; Simpson, Richard J; Salim, Agus; Bacic, Antony; Hill, Andrew F; Stroud, David A; Ryan, Michael T; Agbinya, Johnson I; Mariadason, John M ; Burgess, Antony W; Mathivanan, Suresh
465-May-2015Highly expressed genes in rapidly proliferating tumor cells as new targets for colorectal cancer treatmentBazzocco, Sarah; Andretta, Elena; Rodrigues, Paulo; Garrido, Miriam; Alazzouzi, Hafid; Chionh, Fiona; Carton-Garcia, Fernando; Macaya, Irati; Nieto, Rocio; Sanchez, Alex; Schwartz, Simo; Dopeso, Higinio; Bilic, Josipa; Mariadason, John M ; Arango, Diego
472-Feb-2015Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer.Pereira, Lloyd; Mariadason, John M ; Hannan, Ross D; Dhillon, Amardeep S
4821-Nov-2014RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.Rodrigues, Paulo; Macaya, Irati; Bazzocco, Sarah; Mazzolini, Rocco; Andretta, Elena; Dopeso, Higinio; Mateo-Lozano, Silvia; Bilić, Josipa; Cartón-García, Fernando; Nieto, Rocio; Suárez-López, Lucia; Afonso, Elsa; Landolfi, Stefania; Hernandez-Losa, Javier; Kobayashi, Kazuto; Cajal, Santiago Ramón Y; Tabernero, Josep; Tebbutt, Niall C ; Mariadason, John M ; Schwartz, Simo; Arango, Diego
4918-Jul-2014The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.Shin, Joongho; Carr, Azadeh; Corner, Georgia A; Tögel, Lars; Dávaos-Salas, Mercedes; Tran, Hoanh; Chueh, Anderly C; Al-Obaidi, Sheren; Chionh, Fiona; Ahmed, Naseem; Buchanan, Daniel D; Young, Joanne P; Malo, Madhu S; Hodin, Richard A; Arango, Diego; Sieber, Oliver M; Augenlicht, Leonard H; Dhillon, Amardeep S; Weber, Thomas K; Mariadason, John M 
5022-Apr-2014Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.Mouradov, Dmitri; Sloggett, Clare; Jorissen, Robert N; Love, Christopher G; Li, Shan; Burgess, Antony W; Arango, Diego; Strausberg, Robert L; Buchanan, Daniel; Wormald, Samuel; O'Connor, Liam; Wilding, Jennifer L; Bicknell, David; Tomlinson, Ian P M; Bodmer, Walter F; Mariadason, John M ; Sieber, Oliver M
5127-Mar-2014Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells.Chueh, Anderly C; Tse, Janson W T; Tögel, Lars; Mariadason, John M 
5220-Feb-2014Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity.Ung, Nelson; Putoczki, Tracy L; Stylli, Stanley S; Ng, Irvin; Mariadason, John M ; Chan, Timothy A; Zhu, Hong-Jian; Luwor, Rodney B
5315-Jan-2014FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.Tan, BeeShin; Anaka, Matthew; Deb, Siddhartha; Freyer, Claudia; Ebert, Lisa M; Chueh, Anderly C; Al-Obaidi, Sheren; Behren, Andreas; Jayachandran, Aparna; Cebon, Jonathan S ; Chen, Weisan; Mariadason, John M 
544-Nov-2013BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.Andrews, Miles C; Behren, Andreas; Chionh, Fiona; Mariadason, John M ; Vella, Laura J; Do, Hongdo; Dobrovic, Alexander ; Tebbutt, Niall C ; Cebon, Jonathan S 
5517-Sep-2013Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008.Burvenich, Ingrid J G; Lee, Fook-Thean; Cartwright, Glenn A; O'Keefe, Graeme J; Makris, Dahna; Cao, Diana; Gong, Sylvia J; Chueh, Anderly C; Mariadason, John M ; Brechbiel, Martin W; Beckman, Robert A; Fujiwara, Kosaku; von Roemeling, Reinhard; Scott, Andrew M 
5615-Apr-2011Biomarkers of 5-FU response in colon cancer.Mariadason, John M ; Tebbutt, Niall C 
571-Dec-2010Strategies for overcoming inherent and acquired resistance to EGFR inhibitors by targeting downstream effectors in the RAS/PI3K pathway.Weickhardt, Andrew J ; Tebbutt, Niall C ; Mariadason, John M